The European Medicines Agency said on Wednesday 22 July that it is ready to monitor the effectiveness and safety of Covid-19 treatments and vaccines once they are on the market.
In a press release, the EU agency states that the necessary infrastructure has been put in place. It refers to three observational research contracts concluded with academic and private partners in recent months.
The first project is entitled ACCESS (“vACcine Covid-19 monitoring readinESS”) and is preparatory...